These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23949920)

  • 1. Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer.
    Vlug EJ; van de Ven RA; Vermeulen JF; Bult P; van Diest PJ; Derksen PW
    Cell Oncol (Dordr); 2013 Oct; 36(5):375-84. PubMed ID: 23949920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.
    Vermeulen JF; van de Ven RA; Ercan C; van der Groep P; van der Wall E; Bult P; Christgen M; Lehmann U; Daniel J; van Diest PJ; Derksen PW
    PLoS One; 2012; 7(5):e37864. PubMed ID: 22662240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells.
    Qin X; Li J; Sun J; Liu L; Chen D; Liu Y
    Biochem Biophys Res Commun; 2019 Mar; 510(2):219-223. PubMed ID: 30685085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP expression in normal and neoplastic breast tissue: an immunohistochemical study.
    Jaramillo-Rodríguez Y; Cerda-Flores RM; Ruiz-Ramos R; López-Márquez FC; Calderón-Garcidueñas AL
    Arch Med Res; 2014 Apr; 45(3):223-8. PubMed ID: 24606817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner.
    Lee Y; Kim NH; Cho ES; Yang JH; Cha YH; Kang HE; Yun JS; Cho SB; Lee SH; Paclikova P; Radaszkiewicz TW; Bryja V; Kang CG; Yuk YS; Cha SY; Kim SY; Kim HS; Yook JI
    Nat Commun; 2018 Jun; 9(1):2301. PubMed ID: 29895829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation.
    Song Q; Mao B; Cheng J; Gao Y; Jiang K; Chen J; Yuan Z; Meng S
    PLoS One; 2015; 10(3):e0120790. PubMed ID: 25811979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.
    Cao L; Sun PL; Yao M; Jia M; Gao H
    Hum Pathol; 2017 Oct; 68():166-174. PubMed ID: 28899737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between YAP expression in neoplastic and non-neoplastic breast tissue with arsenic urinary levels.
    Michel-Ramirez G; Recio-Vega R; Ocampo-Gomez G; Palacios-Sanchez E; Delgado-Macias M; Delgado-Gaona M; Lantz RC; Gandolfi J; Gonzalez-Cortes T
    J Appl Toxicol; 2017 Oct; 37(10):1195-1202. PubMed ID: 28524356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer.
    Tsujiura M; Mazack V; Sudol M; Kaspar HG; Nash J; Carey DJ; Gogoi R
    PLoS One; 2014; 9(6):e100974. PubMed ID: 24972085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
    Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
    Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
    J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.
    Smoot RL; Werneburg NW; Sugihara T; Hernandez MC; Yang L; Mehner C; Graham RP; Bronk SF; Truty MJ; Gores GJ
    J Cell Biochem; 2018 Jan; 119(1):824-836. PubMed ID: 28661054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
    Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
    Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures.
    Tasdemir N; Bossart EA; Li Z; Zhu L; Sikora MJ; Levine KM; Jacobsen BM; Tseng GC; Davidson NE; Oesterreich S
    Cancer Res; 2018 Nov; 78(21):6209-6222. PubMed ID: 30228172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.
    Di Agostino S; Sorrentino G; Ingallina E; Valenti F; Ferraiuolo M; Bicciato S; Piazza S; Strano S; Del Sal G; Blandino G
    EMBO Rep; 2016 Feb; 17(2):188-201. PubMed ID: 26691213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nuclear insulin receptor substrate 1 in breast cancer.
    Sisci D; Morelli C; Garofalo C; Romeo F; Morabito L; Casaburi F; Middea E; Cascio S; Brunelli E; Andò S; Surmacz E
    J Clin Pathol; 2007 Jun; 60(6):633-41. PubMed ID: 16882697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.